To target and kill cancer cells, oncolytic viruses exploit signaling pathways that promote tumor growth. A new study shows that the cancer stromal fibroblast factor FGF2 is a crucial component of a tumor–TGF-β axis that renders cancer cells sensitive to virus infection.
References
Chiocca, E.A. & Rabkin, S.D. Cancer Immunol. Res. 2, 295–300 (2014).
Aghi, M.K. & Chiocca, E.A. Mol. Ther. 17, 8–9 (2009).
Markert, J.M. et al. Mol. Ther. 17, 199–207 (2009).
Ilkow, C.S. et al. Nat. Med. 21, 530–536 (2015).
Junttila, M.R. & de Sauvage, F.J. Nature 501, 346–354 (2013).
Kalluri, R. & Zeisberg, M. Nat. Rev. Cancer 6, 392–401 (2006).
Tripathi, M., Billet, S. & Bhowmick, N.A. Cell Adhes. Migr. 6, 231–235 (2012).
Finak, G. et al. Nat. Med. 14, 518–527 (2008).
Chiocca, E.A. Curr. Opin. Mol. Ther. 10, 38–45 (2008).
Alvarez-Breckenridge, C.A. et al. Nat. Med. 18, 1827–1834 (2012).
Workenhe, S.T. & Mossman, K.L. Mol. Ther. 22, 251–256 (2014).
McMillin, D.W., Negri, J.M. & Mitsiades, C.S. Nat. Rev. Drug Discov. 12, 217–228 (2013).
Kojima, Y. et al. Proc. Natl. Acad. Sci. USA 107, 20009–20014 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Bronisz, A., Chiocca, E. A cross-talk network that facilitates tumor virotherapy. Nat Med 21, 426–427 (2015). https://doi.org/10.1038/nm.3857
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3857
- Springer Nature America, Inc.